Financials

News Discussions Technicals Forecast Seasonals Options

AVBP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of ArriVent BioPharma, Inc.

Total assets of AVBP for Q1 25 is 215.50 M USD, 21.62% less than the previous Q4 24. And total liabilities decreased by 25.08% in Q1 25 to 12.95 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—